BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12358773)

  • 1. Membrane-bound histamine N-methyltransferase in mouse brain: possible role in the synaptic inactivation of neuronal histamine.
    Barnes WG; Hough LB
    J Neurochem; 2002 Sep; 82(5):1262-71. PubMed ID: 12358773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histamine
    Yoshikawa T; Nakamura T; Yanai K
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30744146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a new mRNA species from the human histamine N-methyltransferase gene.
    Barnes WG; Grinde E; Crawford DR; Herrick-Davis K; Hough LB
    Genomics; 2004 Jan; 83(1):168-71. PubMed ID: 14667820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of brain histamine clearance using genetically engineered mice].
    Yoshikawa T; Nakamura T; Yanai K
    Nihon Yakurigaku Zasshi; 2018; 152(1):16-20. PubMed ID: 29998947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in molecular pharmacology of the histamine systems: organic cation transporters as a histamine transporter and histamine metabolism.
    Ogasawara M; Yamauchi K; Satoh Y; Yamaji R; Inui K; Jonker JW; Schinkel AH; Maeyama K
    J Pharmacol Sci; 2006 May; 101(1):24-30. PubMed ID: 16648665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histamine N-methyltransferase regulates aggression and the sleep-wake cycle.
    Naganuma F; Nakamura T; Yoshikawa T; Iida T; Miura Y; Kárpáti A; Matsuzawa T; Yanai A; Mogi A; Mochizuki T; Okamura N; Yanai K
    Sci Rep; 2017 Nov; 7(1):15899. PubMed ID: 29162912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of astrocytic histamine N-methyltransferase to histamine clearance and brain function in mice.
    Otsuka R; Naganuma F; Nakamura T; Miwa H; Nakayama-Naono R; Matsuzawa T; Komatsu Y; Sato Y; Takahashi Y; Tatsuoka-Kitano H; Yanai K; Yoshikawa T
    Neuropharmacology; 2022 Jul; 212():109065. PubMed ID: 35487272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse kidney histamine N-methyltransferase: assay conditions, biochemical properties and strain variation.
    Scott MC; Guerciolini R; Szumlanski C; Weinshilboum RM
    Agents Actions; 1991 Mar; 32(3-4):194-202. PubMed ID: 1907425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of N-methylation: heritability of human erythrocyte histamine N-methyltransferase activity.
    Scott MC; Van Loon JA; Weinshilboum RM
    Clin Pharmacol Ther; 1988 Mar; 43(3):256-62. PubMed ID: 3345617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is neurotransmitter histamine predominantly inactivated in astrocytes?
    Rafałowska U; Waśkiewicz J; Albrecht J
    Neurosci Lett; 1987 Sep; 80(1):106-10. PubMed ID: 2889175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism of histamine clearance by primary human astrocytes.
    Yoshikawa T; Naganuma F; Iida T; Nakamura T; Harada R; Mohsen AS; Kasajima A; Sasano H; Yanai K
    Glia; 2013 Jun; 61(6):905-16. PubMed ID: 23505051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histamine N-methyltransferase: inhibition by monoamine oxidase inhibitors.
    Boudíková-Girard B; Scott MC; Weinshilboum R
    Agents Actions; 1993 Sep; 40(1-2):1-10. PubMed ID: 8147263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interindividual variability of histamine N-methyltransferase in the human liver and kidney.
    De Santi C; Donatelli P; Giulianotti PC; Pietrabissa A; Mosca F; Pacifici GM
    Xenobiotica; 1998 Jun; 28(6):571-7. PubMed ID: 9667080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of Motion Sickness Through Targeting Histamine
    Chen MM; Xu LH; Chang L; Yin P; Jiang ZL
    J Pharmacol Exp Ther; 2018 Mar; 364(3):367-376. PubMed ID: 29298819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theoretical 3D model of histamine N-methyltransferase: insights into the effects of a genetic polymorphism on enzymatic activity and thermal stability.
    Pang YP; Zheng XE; Weinshilboum RM
    Biochem Biophys Res Commun; 2001 Sep; 287(1):204-8. PubMed ID: 11549275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of histamine-N-methyltransferase (HNMT) by fragments of 9-amino-1,2,3,4-tetrahydroacridine (tacrine) and by beta-carbolines.
    Cumming P; Vincent SR
    Biochem Pharmacol; 1992 Sep; 44(5):989-92. PubMed ID: 1530666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human histamine N-methyltransferase pharmacogenetics: cloning and expression of kidney cDNA.
    Girard B; Otterness DM; Wood TC; Honchel R; Wieben ED; Weinshilboum RM
    Mol Pharmacol; 1994 Mar; 45(3):461-8. PubMed ID: 8145732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexually Dimorphic Effects of Histamine Degradation by Enteric Glial Histamine
    McClain JL; Morales-Soto W; Gonzales J; Parmar V; Demireva EY; Gulbransen BD
    Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of the binding sites of human histamine N-methyltransferase (HNMT) monoclonal antibodies.
    Schwelberger HG; Feurle J; Houen G
    Inflamm Res; 2017 Nov; 66(11):1021-1029. PubMed ID: 28791419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human histamine N-methyltransferase pharmacogenetics: common genetic polymorphisms that alter activity.
    Preuss CV; Wood TC; Szumlanski CL; Raftogianis RB; Otterness DM; Girard B; Scott MC; Weinshilboum RM
    Mol Pharmacol; 1998 Apr; 53(4):708-17. PubMed ID: 9547362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.